![Ignasi Heras Vila](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ignasi Heras Vila
Private Equity Investor bij
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Profiel
Ignasi Heras Vila is the founder of Transplant Biomedicals SL.
He is currently working as the General Partner at Cross Road Biotech Inversiones Biotecnologicas SGEIC SA. Previously, he worked as the Principal at Nina Capital SGEIC SA from 2018 to 2020.
Mr. Heras Vila completed his undergraduate degree at the University of Barcelona in 2007 and obtained an MBA from EADA Business School in 2013.
Actieve functies van Ignasi Heras Vila
| Bedrijven | Functie | Begin |
|---|---|---|
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Private Equity Investor | 01-01-2023 |
Eerdere bekende functies van Ignasi Heras Vila
| Bedrijven | Functie | Einde |
|---|---|---|
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Private Equity Investor | 01-02-2020 |
Transplant Biomedicals SL
 Transplant Biomedicals SL Medical/Nursing ServicesHealth Services Develops organs, tissues and cells preservation and transportation solutions | Oprichter | - |
Opleiding van Ignasi Heras Vila
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
63
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Barcelona
 University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Finance |
EADA Business School
 EADA Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transplant Biomedicals SL
Transplant Biomedicals SL Medical/Nursing ServicesHealth Services Develops organs, tissues and cells preservation and transportation solutions | Health Services |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Finance |
